MENU
FGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
FibroGen (FGEN) Ownership - Who owns FibroGen?
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
409 Illinois Street
Phone
+1 415 978-1200
Employees
486
Web
https://www.fibrogen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
30.9M
P/E Ratio
N/A
Total Cash
131M
Projected Growth
N/A
Total Debt
79.34M
Revenue
180.02M
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash/Share
1.30
Total Debt/Equity
N/A
Revenue/Share
0.30 USD as % of share price
Fundamentals
FGEN
Capitalization
30.9M
P/E Ratio
N/A
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash
131M
Total Cash/Share
1.30
Total Debt
79.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.30%
Revenue
180M
ROE
N/A
Book Value
-243.67M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.01M
Current Ratio
1.28
Current Revenue Per Employee
95335.39
Dividends Per Share - Security
N/A
EBITDA
-101.15M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.57
Revenue To Assets
-33.61
Shares Held By Institutions
19.7M
Shares Outstanding - Current
101M
Total Liabilities
466M
Total Volume MTD
N/A
Value
-1
Gain YTD
-43.324
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biotechnology-based drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
409 Illinois Street
Phone
+1 415 978-1200
Employees
486
Web
https://www.fibrogen.com